Atlas Trials

A Study to Evaluate the Effectiveness of 5-Azacitidine and Bevacizumab in Advanced Renal Cell Carcinoma

Clinical trial NCT00934440 · TERMINATED

Trial details

NCT number
NCT00934440
Sponsor
University of Kansas Medical Center
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Renal Cell Carcinoma
Start date
2009-06-01
Primary completion
2015-11-01
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.